Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a rare but potentially life-threatening complication of acute pulmonary embolism, characterized by persistent pulmonary hypertension due to organized thromboembolic obstruction of the pulmonary arteries. While CTEPH shares similarities with other forms of pulmonary hypertension, it presents unique challenges in terms of diagnosis, treatment and prognosis. This review provides an overview of the comorbidities associated with CTEPH, current treatment options and factors influencing survival in patients with this condition. Understanding the complex interplay between comorbidities, treatment strategies and survival outcomes is essential for optimizing the management of CTEPH and improving patient outcomes.
HTML PDFShare this article
Journal of Hypertension: Open Access received 614 citations as per Google Scholar report
